OAR 855-041-7050: Definitions - Long Term Care Pharmacy

As used in OAR 855-041-7000 through 855-041-7080: (1) "Long term care facility" means a facility with permanent facilities that include inpatient beds, providing medical services, including nursing services but excluding surgical procedures except as may be permitted by the rules of the director, to provide treatment for two or more unrelated patients. "Long Term Care facility" includes skilled nursing facilities and intermediate care facilities but may not be construed to include facilities licensed and operated pursuant to ORS 443.400 to 443.455. (2) For the purposes of Schedule II prescriptions in 21 CFR 1306.11 (v. 04/01/2025), 21 CFR 1306.12 (v. 04/01/2025), 21 CFR 1306.13 (v. 04/01/2025), 21 CFR 1306.14 (v. 04/01/2025), and 21 CFR 1306.15 (v. 04/01/2025), the DEA definition of "long term care facility" as defined in 21 CFR 1300.01 (v. 04/01/2025) includes "community-based care facilities." (3) "Community Based Care Facility" means a home, facility or supervised living environment licensed or certified or otherwise recognized by an agency of the state of Oregon which provides 24-hour care, supervision, and assistance with medication administration. These include but are not limited to Adult Foster Homes, Residential Care Facilities (RCF), Assisted Living Facilities (ALF), Intermediate Care Facilities for Individuals with Intellectual Disabilities and Inpatient Hospice. (4) "Pharmaceutical Care" means the responsible provision of any or all of the following services by the pharmacist: (a) Develop and maintain policies and procedures for pharmaceutical services; (b) Provide direction and oversight regarding all aspects of the acquisition, disposition, handling, storage, and administration of drugs including but not limited to the following: (A) Receipt and interpretation of physician's orders; (B) Ordering and receiving of medications; (C) Handling of emergency drugs and supplies; (D) Labeling of all drugs; (E) Selection of drug delivery systems; (F) Development of systems to provide timely delivery of drugs and supplies; (G) Monitoring of drug storage conditions and expiration dates; (H) Monitoring accuracy and efficiency of medication administration and compliance with physician's orders; (I) Establishing and monitoring of appropriate record keeping; (J) Accountability of controlled substances; (K) Return, release, and/or destruction of discontinued or outdated drugs; and (L) Compliance with state and federal laws and regulations related to pharmaceutical services and medication management. (c) Provide training and in-service education to facility staff; (d) Perform drug regimen review for each resident on a regularly scheduled basis for the purpose of promoting therapeutic appropriateness and achieving the desired drug therapy outcomes by identifying issues such as: (A) Over-utilization or underutilization; (B) Therapeutic duplication; (C) Drug-disease contraindications; (D) Drug-drug interactions; (E) Incorrect drug, drug dosage or duration of drug treatment; (F) Drug-allergy interaction; (G) Clinical abuse/misuse; (H) Untreated indication; (I) Monitoring and assessing of drug therapy outcomes; (e) Communicate effectively with residents' physicians and facility staff; and (f) Participate in resident care planning. [Publications: Publications referenced are available for review at the agency.]